Institutional Corruption and Pharmaceutical Policy

0
187

Harvard’s Safra Center has put together an extremely valuable “symposium of 16 articles that investigate the corruption of pharmaceutical policy, each taking a different look at the sources of corruption, how it occurs and what is corrupted. The articles address five topics: (1) systemic problems, (2) medical research, (3) medical knowledge and practice, (4) marketing, and (5) patient advocacy organizations.”

Article →

Institutional Corruption and Pharmaceutical Policy
An Edmond J. Safra Center Symposium 
Harvard University
Journal of Law, Medicine and Ethics 
Vol. 14, No. 3 (2013)
1. SYSTEMIC PROBLEMS
2. MEDICAL RESEARCH
3. MEDICAL KNOWLEDGE AND PRACTICE
4. MARKETING
5. PATIENT ADVOCATES

Hat tip to 1BoringOldMan and Ben Goldacre

Previous article2X Risk of Postpartum Hemorrhage Antidepressants
Next articlePolly Trope – Op-Ed Bio
Kermit Cole
Kermit Cole, MFT, founding editor of Mad in America, works in Santa Fe, New Mexico as a couples and family therapist. Inspired by Open Dialogue, he works as part of a team and consults with couples and families that have members identified as patients. His work in residential treatment — largely with severely traumatized and/or "psychotic" clients — led to an appreciation of the power and beauty of systemic philosophy and practice, as the alternative to the prevailing focus on individual pathology. A former film-maker, he has undergraduate and master's degrees in psychology from Harvard University, as well as an MFT degree from the Council for Relationships in Philadelphia. He is a doctoral candidate with the Taos Institute and the Free University of Brussels. You can reach him at [email protected]